Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA; School of Medicine, Saint Joseph University, Beirut, Lebanon.
Clin Neurol Neurosurg. 2023 Oct;233:107916. doi: 10.1016/j.clineuro.2023.107916. Epub 2023 Jul 28.
The transfemoral (TF) route has historically been the preferred access site for endovascular procedures. However, despite its widespread use, TF procedures may confer morbidity as a result of access site complications. The aim of this study is to provide the rate and predictors of TF access site complications for neuroendovascular procedures.
This is a single center retrospective study of TF neuroendovascular procedures performed between 2017 and 2022. The incidence of complications and associated risk factors were analyzed across a large cohort of patients.
The study comprised of 2043 patients undergoing transfemoral neuroendovascular procedures. The composite rate of access site complications was 8.6 % (n = 176). These complications were divided into groin hematoma formation (n = 118, 5.78 %), retroperitoneal hematoma (n = 14, 0.69 %), pseudoaneurysm formation (n = 40, 1.96 %), and femoral artery occlusion (n = 4, 0.19 %). The cross-over to trans radial access rate was 1.1 % (n = 22). On univariate analysis, increasing age (OR=1.0, p = 0.06) coronary artery disease (OR=1.7, p = 0.05) peripheral vascular disease (OR=1.9, p = 0.07), emergent mechanical thrombectomy procedures (OR=2.1, p < 0.001) and increasing sheath size (OR=1.3, p < 0.001) were associated with higher TF access site complications. On multivariate analysis, larger sheath size was an independent risk factor for TF access site complications (OR=1.8, p = 0.02).
Several pertinent factors contribute towards the incidence of TF access site complications. Factors associated with TF access site complications include patient demographics (older age) and clinical risk factors (vascular disease), as well as periprocedural factors (sheath size).
经股(TF)入路一直是血管内治疗的首选入路。然而,尽管其应用广泛,但 TF 入路可能会因入路并发症而导致发病率。本研究旨在提供神经血管介入治疗中 TF 入路并发症的发生率和预测因素。
这是一项 2017 年至 2022 年期间进行的经股神经血管介入治疗的单中心回顾性研究。分析了大量患者的并发症发生率和相关危险因素。
研究包括 2043 例行 TF 神经血管介入治疗的患者。TF 入路并发症的复合发生率为 8.6%(n=176)。这些并发症分为腹股沟血肿形成(n=118,5.78%)、腹膜后血肿(n=14,0.69%)、假性动脉瘤形成(n=40,1.96%)和股动脉闭塞(n=4,0.19%)。交叉至经桡动脉入路的比例为 1.1%(n=22)。单因素分析显示,年龄增长(OR=1.0,p=0.06)、冠状动脉疾病(OR=1.7,p=0.05)、外周血管疾病(OR=1.9,p=0.07)、紧急机械血栓切除术(OR=2.1,p<0.001)和鞘管尺寸增大(OR=1.3,p<0.001)与 TF 入路并发症的发生相关。多因素分析显示,鞘管尺寸较大是 TF 入路并发症的独立危险因素(OR=1.8,p=0.02)。
几个相关因素导致了 TF 入路并发症的发生率。与 TF 入路并发症相关的因素包括患者的人口统计学特征(年龄较大)和临床危险因素(血管疾病),以及围手术期因素(鞘管大小)。